Evonik: Ebitda falls 24% on organic sales growth of 1%; reiterates outlook for 2014
13:30 PM | May 7, 2014 | Michael Ravenscroft
Evonik says it achieved sales of €320 billion ($4.45 billion) in first-quarter 2014, close to the prior-period level of €3.21 billion, a slight organic sales growth of 1% year-on- year. Higher volumes...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.